Home > Healthcare & Medical Devices > Ablation Devices Market

Ablation Devices Market Size By Technology (Radiofrequency Devices, Laser/Light Ablation, Ultrasound Devices, Cryoablation Devices), By Application (Cardiology, Oncology, Ophthalmology, Gynecology, Urology, Cosmetic Surgery), By End-use (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Covid-19 Impact Analysis, Growth Potential, Competitive Market Share & Forecast, 2022 – 2028

  • Report ID: GMI3419
  • Published Date: Feb 2022
  • Report Format: PDF

Industry Overview

Ablation Devices Market size surpassed 7.5 billion in 2021 and is poised to grow at 11.2% CAGR through 2028 driven by new product developments in the market with technological advancements in ablation devices by the industry players will drive the ablation devices market growth.

Get more details on this report - Request Free Sample PDF

Furthermore, rising adoption of robotic technologies for the expansion of product applications and integration of latest technologies in ablation devices to offer enhanced patient safety as well as procedural efficiency will drive the market size.

For instance, in June 2020, Boston Scientific Corporation launched the DIRECTSENSE technology to monitor radiofrequency energy delivery effects during cardiac ablation procedures. This radiofrequency ablation device emits radio waves leading to heating of a small portion of nervous tissue for sending signals to minimize the pain. Such advancements are expected to augment the adoption of ablation devices.

The COVID 19 pandemic has negatively impacted ablation devices market growth in 2020, however, the industry gained momentum in 2021 with declining number of COVID-19 cases. Adoption of standard operating protocols, preventive measures and reduced mortality rate associated with COVID-19 led to continuation of other operational procedures in healthcare facilities with minimized risk of infection. Thus, with decrease in the number of COVID-19 cases in some regions during the financial year 2021, the market experienced gradual growth in revenue.

Ablation devices are medical instruments used in minimally invasive procedures to remove or excise aberrant body tissues for therapeutic purposes. These systems utilize heat that can be generated by radio frequency, energy, extreme cold or a laser to cause small burns.

Increasing patient preference for minimally invasive procedures will impel the market forecasts

Patient preference for minimally invasive procedures over open surgeries is one of the prominent factors contributing to the overall market share. Significant increase in popularity and acceptance of minimally invasive treatments due to shorter hospital stay, faster recovery and less pain as compared to the traditional surgeries have been observed in recent years.

Furthermore, growing prevalence of atrial fibrillation among population will positively impact the number of cardiac ablation procedures. Minimally invasive ablation procedure for atrial fibrillation offers maximum efficacy, low risk and more convenience to the patients. Thus, increasing benefits of less invasive treatment procedures with adoption of ablation devices will drive the ablation devices market during the forecast period.

Development of innovative and advanced cryoablation systems will augment the industry statistics

Get more details on this report - Request Free Sample PDF

Based on technology, ablation devices market is segmented into radiofrequency devices, laser/light ablation, ultrasound devices, cryoablation devices, and others. The cryoablation devices segment was valued at over USD 600 million in 2021 owing to expanding research and development activities for advanced therapeutic procedures to treat chronic diseases. Additionally, several advantages associated with cryoablation devices such as minimal invasions as compared to open surgery, fewer side effects and less injury to surrounding tissues are expected to propel the segment demand in the coming years.

Upsurge in demand for the ablation devices in cancer treatment will strengthen the market growth potential

Based on application, ablation devices market is segmented into cardiology, oncology, ophthalmology, gynecology, urology, cosmetic surgery, and others. The oncology segment is forecast to grow at 11.9% CAGR through 2028 owing to an increasing prevalence of cancer and associated risk of mortality. According to the report published by the National Institute of Cancer in 2018, around 18.1 million new cases were reported globally. Thus, to treat cancer with higher safety and efficiency, the demand for ablation technology is expected to witness considerable growth in nearby future.

Availability of skilled expertise influence the patient preference for hospitals

Get more details on this report - Request Free Sample PDF

Based on end use, the hospitals segment held nearly 50% market share in 2021 and is anticipated to witness substantial growth during the forecast period. Expanding number of hospitals and availability of advanced treatments options is projected to drive the patient preference towards hospitals. Furthermore, presence of skilled healthcare professional and extensive efforts by the market players to educate and inform professionals regarding available advanced ablation technologies in market will impel the ablation devices market value.

Adoption of technologically advanced devices with higher disease prevalence in North America will drive the market forecasts

Get more details on this report - Request Free Sample PDF

North America market held over 40% revenue share in overall ablation devices market in 2021. Growing prevalence of cancer along with other chronic diseases and rising geriatric population are some of the key factors driving the regional market growth. According to the American Cancer Society, in 2018, around 1.9 million new cases of cancer and approximately 693,000 mortalities were reported in the region.

Additionally, geriatric population is more prone to several chronic conditions due to structural changes with aging leading to the increasing demand for treatment procedures that will positively impact the product adoption in the North American market. Furthermore, developed healthcare infrastructure coupled with increasing adoption of technologically advanced ablation devices is projected to propel the regional market trends.

Increasing number of product launches and strategic partnerships among the market players will benefit the market size

The global ablation devices industry consists of numerous players. Few of the prominent market players operating in ablation devices are Abbott Laboratories, Alcon Laboratories, AngioDynamics, AtriCure, Inc, Bausch & Lomb Incorporated, Biotronik SE & Co. KG, Boston Scientific Corporation, CONMED Corporation, Elekta AB, Olympus Corporation, Varian, Medtronic plc, and Ethicon, Inc (Johnson & Johnson) among others. These market players are actively involved in technological advancements and strategic collaboration to expand their product portfolio.

Some of the recent industry developments:

  • In November 2021, Medtronic launched Arctic Front Cardiac Cryoablation Catheter System in India used for the treatment of atrial fibrillation (AF). This has assisted the company in strengthening its product portfolio of ablation devices, thereby offering revenue growth opportunities in the market.
  • In July 2020, Ethicon, Inc (Johnson & Johnson), announced that the U.S. FDA has approved breakthrough device designation to its transbronchial microwave ablation technology. The technology offers more effective treatment or diagnosis of life-threatening debilitating diseases. Hence, such approvals are positively impacting the company’s growth.

The ablation devices market report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2022 to 2028 for the following segments:

By Technology

  • Radiofrequency Devices
  • Laser/Light Ablation
  • Ultrasound Devices
  • Cryoablation Devices
  • Others

By Application

  • Cardiology
  • Oncology
  • Ophthalmology
  • Gynecology
  • Urology
  • Cosmetic Surgery
  • Others

By End-use

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

The above information is provided for the following regions and countries:

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Others


Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

In 2021, ablation devices industry share crossed 7.5 billion and is poised to grow at a CAGR of 11.2% by 2028 owing to constant technological advancements and new product launches.
Cryoablation devices industry size was recorded at USD 600 million in 2021 and could grow due to increasing R&D activities for advanced therapeutic procedures for treating chronic diseases.
Ablation devices market revenue from oncology application is estimated to grow at a CAGR of 11.9% over 2022-2028 with growing incidences of cancer and the mortality risks associated with it.
Hospitals accounted for about 50% of the overall market share in 2021 owing to the availability of advanced treatment options and increasing number of hospitals.
North America ablation devices market captured more than 40% of the overall revenue share in 2021 and could grow with the increasing elderly population and rising prevalence of chronic diseases.

Buy Now

Premium Report Details

  • Base Year: 2021
  • Companies covered: 13
  • Tables & Figures: 185
  • Countries covered: 15
  • Pages: 150
  • Upcoming Report: Details can be customized to meet your information and data needs. Feel free to share your detailed research requirements via this form.

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount